Journal of Scientific & Industrial Research · 2007 · 20 citations · 3 references
Open access
PharmacyMedicinal ChemistryPharmacologyDrug DeliveryDrug DiscoveryProdrug DesignAntifungal AgentsBioconjugation ChemistryConjugation ReactionsNatural Product DerivatizationAntibacterial ProdrugsConjugationConjugation EffectsDisulfide-based ProdrugsNatural Product ConjugatesPeptide ConjugatesPeptide-drug ConjugatesProdrug-drug Conjugates
Mixed bioconjugates of curcumin [4,4'-di-O-(glycinoyl-cystinoyl) curcumin, 4,4'-di- O-(glycinoyl-cysteinoyl) curcumin, 4,4'-di-O-L-(alaninoyl) curcumin, 4,4'-di-(O- glycinoyl)-glycinoyl) curcumin and 4,4'-di-O{(3,4,5-O-acetyl) galloyl} curcumin] have been prepared and characterized. These bioconjugates contain biodegradable (ester and peptide) bonds and have been tested for antifungal and anti bacterial activities, which have been found to be considerably enhanced vis-a-vis curcumin. The plausible reasons for this remarkable enhancement in therapeutic activity may be due to better cellular uptake, increased cellular concentration, better receptor binding at the target sites due to extended conjugation. These conjugates may act as potent prodrugs since these can get enzymatically hydrolysed at the target sites.
3